Vivakor Announces The Launch Of Its Second Generation VivaThermic Cryovials Designed Specifically For Stem Cell Research

Vivakor, Inc. (OTCBB: VIVK) announced the development of its second generation VivaThermic Cryovials. The VivaThermic 2.0 cryovials were specifically designed to facilitate improved cryopreservation of induced Pluripotent Stem cells (iPS cells) and protein-induced Pluripotent Stem cells (piPS). Their use and the ability to cryogenically preserve these cells is a critical and integral part of the most important type of stem research going on today. These cells, as well as human embryonic stem cells, have been shown to be particularly difficult to manage in the cryopreservation process… (Source: Health News from Medical News Today)